These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3689493)

  • 21. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia.
    Agheli N; Cloarec M; Jacotot B
    Ann Nutr Metab; 1991; 35(5):261-73. PubMed ID: 1776822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of dietary-induced hypercholesterolemia in the chicken.
    Hermier D; Dillon JC
    Biochim Biophys Acta; 1992 Mar; 1124(2):178-84. PubMed ID: 1543739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A high-cholesterol, n-3 polyunsaturated fatty acid diet causes different responses in rats and hamsters.
    Lin MH; Lu SC; Huang PC; Liu YC; Liu SY
    Ann Nutr Metab; 2005; 49(6):386-91. PubMed ID: 16219990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice. A proposed model for drug screening.
    Olivier P; Plancke MO; Marzin D; Clavey V; Sauzieres J; Fruchart JC
    Atherosclerosis; 1988 Mar; 70(1-2):107-14. PubMed ID: 3162679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of dietary fat, protein, cholesterol, and fiber intake to atherogenic lipoproteins in men.
    Williams PT; Krauss RM; Kindel-Joyce S; Dreon DM; Vranizan KM; Wood PD
    Am J Clin Nutr; 1986 Dec; 44(6):788-97. PubMed ID: 3024477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in plasma lipoprotein concentrations and compositions upon feeding cholesterol in high- and low-responding rhesus monkeys.
    Myers LH; Bhattacharyya AK; Eggen DA; Strong JP
    Ann Nutr Metab; 1990; 34(6):317-26. PubMed ID: 2076023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal lipoprotein synthesis in control and hypercholesterolemic rats.
    Swift LL; Gray ME; LeQuire VS
    Biochim Biophys Acta; 1988 Sep; 962(2):186-95. PubMed ID: 3167076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of multiple neurotransmitters in the effects of Lycopene on brain injury induced by Hyperlipidemia.
    Yang W; Shen Z; Wen S; Wang W; Hu M
    Lipids Health Dis; 2018 Feb; 17(1):13. PubMed ID: 29409499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes.
    Sentí M; Nogués X; Pedro-Botet J; Rubiés-Prat J; Vidal-Barraquer F
    Circulation; 1992 Jan; 85(1):30-6. PubMed ID: 1728461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
    Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels.
    Alaupovic P; Heinonen T; Shurzinske L; Black DM
    Atherosclerosis; 1997 Aug; 133(1):123-33. PubMed ID: 9258416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dietary fiber on hypercholesterolemia induced by dietary PCB or cholesterol in rats.
    Quazi S; Yokogoshi H; Yoshida A
    J Nutr; 1983 Jun; 113(6):1109-18. PubMed ID: 6304267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins.
    Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
    Gynecol Obstet Invest; 1980; 11(3):161-9. PubMed ID: 7439809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperlipidemia enhances chronic rejection in experimental rat model.
    Tilly-Kiesi M; Räisänen-Sokolowski A; Ustinov J; Myllärniemi M; Tikkanen MJ; Häyry P
    Transplant Proc; 1995 Feb; 27(1):582. PubMed ID: 7879107
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucomannan and glucomannan plus spirulina added to pork significantly block dietary cholesterol effects on lipoproteinemia, arylesterase activity, and CYP7A1 expression in Zucker fa/fa rats.
    González-Torres L; Vázquez-Velasco M; Olivero-David R; Bastida S; Benedí J; González RR; González-Muñoz MJ; Sánchez-Muniz FJ
    J Physiol Biochem; 2015 Dec; 71(4):773-84. PubMed ID: 26475369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats.
    Ohata I; Sakamoto N; Nagano K; Maeno H
    Biochem Pharmacol; 1984 Jul; 33(14):2199-205. PubMed ID: 6466343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.